Literature DB >> 16158954

Inhibitory effect of fucoidan on the adhesion of adenocarcinoma cells to fibronectin.

Jian Miao Liu1, Jérôme Bignon, Ferial Haroun-Bouhedja, Patrick Bittoun, Jany Vassy, Serge Fermandjian, Johana Wdzieczak-Bakala, Catherine Boisson-Vidal.   

Abstract

Fucoidans inhibit tumour cell adhesion to various substrata, but their mechanisms of action are not fully understood. Using 3H-fucoidan, we observed that fucoidan binds to fibronectin, this binding being saturable and sensitive to ionic strength and pH. The interaction occurred on at least four different sites along the polypeptide chain, two of them being the heparin-binding sequences. Moreover, when MDA-MB-231 tumour cells were exposed to DTAF-fucoidan, internalization occurred and punctuated vesicles were observed in the perinuclear region. The treated cells also showed a different morphology with a cytoskeleton devoid of vinculin and a reorganiztion of the repartition of the integrin-alpha5 subunit on the cell surface. Based on these data, we hypothesize that fucoidan inhibits the adhesion of MDA-MB-231 cells to fibronectin i) by blocking the protein's heparin- and cell-binding domains, ii) by modulating the reorganization of the integrin alpha5 subunit and iii) by down-regulating the expression of vinculin.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16158954

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  17 in total

1.  Inhibitory effects of Fucoidan in 3T3-L1 adipocyte differentiation.

Authors:  Mi-Ja Kim; Un-Jae Chang; Jin-Sil Lee
Journal:  Mar Biotechnol (NY)       Date:  2008-12-10       Impact factor: 3.619

2.  Prunella vulgaris Polysaccharide Inhibits Growth and Migration of Breast Carcinoma-Associated Fibroblasts by Suppressing Expression of Basic Fibroblast Growth Factor.

Authors:  Jian Hao; Xiu-Li Ding; Xue Yang; Xiong-Zhi Wu
Journal:  Chin J Integr Med       Date:  2016-09-01       Impact factor: 1.978

3.  Serum IGF-1 concentrations change with soy and seaweed supplements in healthy postmenopausal American women.

Authors:  Jane Teas; Mohammad R Irhimeh; Susan Druker; Thomas G Hurley; James R Hébert; Todd M Savarese; Mindy S Kurzer
Journal:  Nutr Cancer       Date:  2011-06-28       Impact factor: 2.900

4.  Impact of combined HDAC and mTOR inhibition on adhesion, migration and invasion of prostate cancer cells.

Authors:  Steffen Wedel; Lukasz Hudak; Jens-Michael Seibel; Jasmina Makarević; Eva Juengel; Igor Tsaur; Christoph Wiesner; Axel Haferkamp; Roman A Blaheta
Journal:  Clin Exp Metastasis       Date:  2011-03-31       Impact factor: 5.150

5.  Fucans, but not fucomannoglucuronans, determine the biological activities of sulfated polysaccharides from Laminaria saccharina brown seaweed.

Authors:  Diego O Croci; Albana Cumashi; Natalia A Ushakova; Marina E Preobrazhenskaya; Antonio Piccoli; Licia Totani; Nadezhda E Ustyuzhanina; Maria I Bilan; Anatolii I Usov; Alexey A Grachev; Galina E Morozevich; Albert E Berman; Craig J Sanderson; Maeve Kelly; Patrizia Di Gregorio; Cosmo Rossi; Nicola Tinari; Stefano Iacobelli; Gabriel A Rabinovich; Nikolay E Nifantiev
Journal:  PLoS One       Date:  2011-02-28       Impact factor: 3.240

Review 6.  Fucoidan and cancer: a multifunctional molecule with anti-tumor potential.

Authors:  Farzaneh Atashrazm; Ray M Lowenthal; Gregory M Woods; Adele F Holloway; Joanne L Dickinson
Journal:  Mar Drugs       Date:  2015-04-14       Impact factor: 5.118

7.  The consumption of seaweed as a protective factor in the etiology of breast cancer: proof of principle.

Authors:  Jane Teas; Sylvia Vena; D Lindsie Cone; Mohammad Irhimeh
Journal:  J Appl Phycol       Date:  2012-11-10       Impact factor: 3.215

8.  Effects of oral administration of fucoidan extracted from Cladosiphon okamuranus on tumor growth and survival time in a tumor-bearing mouse model.

Authors:  Kazuo Azuma; Toshitsugu Ishihara; Hiroyuki Nakamoto; Takao Amaha; Tomohiro Osaki; Takeshi Tsuka; Tomohiro Imagawa; Saburo Minami; Osamu Takashima; Shinsuke Ifuku; Minoru Morimoto; Hiroyuki Saimoto; Hitoshi Kawamoto; Yoshiharu Okamoto
Journal:  Mar Drugs       Date:  2012-10-22       Impact factor: 6.085

9.  BB0347, from the lyme disease spirochete Borrelia burgdorferi, is surface exposed and interacts with the CS1 heparin-binding domain of human fibronectin.

Authors:  Robert A Gaultney; Tammy Gonzalez; Angela M Floden; Catherine A Brissette
Journal:  PLoS One       Date:  2013-09-27       Impact factor: 3.240

10.  Fucoidan reduces secretion and expression of vascular endothelial growth factor in the retinal pigment epithelium and reduces angiogenesis in vitro.

Authors:  Michaela Dithmer; Sabine Fuchs; Yang Shi; Harald Schmidt; Elisabeth Richert; Johann Roider; Alexa Klettner
Journal:  PLoS One       Date:  2014-02-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.